SCHEMBL20108909

SCHEMBL20108909

O=P(c1ccc2ccccc2n1)(c1ccc2ccccc2n1)c1ccc2ccc3ccc(-c4ccccc4)nc3c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.45
NPC1 O15118 9/20 0.45
AR P10275 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
PARP1 P09874 1/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
KDM4E B2RXH2 7/20 0.43
SMN1; SMN2 Q16637 6/20 0.43
MAPT P10636 5/20 0.43
ALDH1A1 P00352 4/20 0.43
GMNN O75496 1/20 0.43
TP53 P04637 1/20 0.43
PKM P14618 1/20 0.43
HPGD P15428 1/20 0.43
THPO P40225 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20108851 0.83 PARP1 (0.44) RAB9APARP1MEN1KMT2AKDM4E
SCHEMBL20108877 0.80 PARP1 (0.43) RAB9ACYP2C9PARP1MEN1KMT2A
SCHEMBL22970621 0.75 NPC1 (0.57) RAB9ANPC1ARCYP3A4CYP1A2
2-Phenylquinoline SCHEMBL44999 0.75 RAB9A (0.73) RAB9ANPC1ARCYP3A4CYP1A2
2-Phenylquinoline SCHEMBL29399739 0.75 RAB9A (0.73) RAB9ANPC1ARCYP3A4CYP1A2
SCHEMBL29441293 0.75 MEN1 (0.59) RAB9ANPC1ARCYP3A4CYP1A2
SCHEMBL1753930 0.75 MEN1 (0.59) RAB9ANPC1ARCYP3A4CYP1A2
SCHEMBL30661315 0.74 RAB9A (0.49) RAB9ANPC1ARCYP3A4CYP1A2
SCHEMBL16401204 0.74 MGAM (0.48) RAB9ANPC1CYP1A2CYP2C9MEN1
SCHEMBL30382206 0.74 MGAM (0.48) RAB9ANPC1CYP1A2CYP2C9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11155543-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same LG DISPLAY CO., LTD. (KR) 2021-10-26 US disclosed
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-03 US disclosed
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME OCIAD2, OCIAD1, PPOX RAB9A 1252/4885NPC1 1701/4885AR 3068/4885
US-11155543-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same OCIAD2, OCIAD1, PPOX RAB9A 1252/4885NPC1 1701/4885AR 3068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.